| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pres &Chief Operating Officer | Pres. &Chief Comm. Officer
1 company
Pernock David is a Pres &Chief Operating Officer at EAGLE PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $14K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 19, 2017 | EGRX Eagle Pharmaceuticals, Inc. | Pres. &Chief Comm. Officer | Buy | 255 | $79.69 | $20,320.95 | +35.9% | |
| May 16, 2017 | EGRX Eagle Pharmaceuticals, Inc. | Pres. &Chief Comm. Officer | Buy | 200 | $82.24 | $16,448.00 | +39.1% | |
| Mar 21, 2017 | EGRX Eagle Pharmaceuticals, Inc. | Pres. &Chief Comm. Officer | Buy | 61 | $83.98 | $5,122.78 | +13.6% | |
| Mar 9, 2017 | EGRX Eagle Pharmaceuticals, Inc. | Pres. &Chief Comm. Officer | Buy | 450 | $77.84 | $35,028.49 | New |